logo
Dark
logo
Adult ADHD
Dark
ADHD Medication Meta-analysis
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults (Review)
Atomoxetine in ADHD Patients who use Marijuana
Do individuals with ADHD become more disinhibited with alcohol?
The Prevalence and Correlates of Adult ADHD in the United States: Results From the National Comorbidity Survey Replication
Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder
Comorbidity in adults with attention-deficit hyperactivity disorder
Toward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studies
Adult ADHD & MRI
ADHD and Executive Function
Persistent ADHD Risk Factors
Does adult ADHD start during childhood?
Evidence for late onset ADHD
ADHD remission patterns in young adults
Persistent and late onset ADHD
Predictors of ADHD persistence in adulthood
Socioeconomic status and ADHD risk
Which symptoms resolve first in ADHD?
ADHD: Working Memory and Alpha Waves
Fitness and Executive Function in ADHD
Dopamine Receptors and ADHD
Anxiety, ADHD, and Cognitive Functioning
Executive functioning in adult ADHD: a meta-analytic review
ADHD Symptoms and Emotional Intelligence
ADHD, Attention, and Task Switching
Dopamine and Motivation in ADHD
ADHD, working memory, and verbal learning
ADHD and Forgetting
Sluggish Cognitive Tempo, ADHD, and Mind-Wandering
Medication and Training for Working Memory in ADHD
Long-Term Memory Performance in Adult ADHD
ADHD Symptoms and the Reward System
ADHD in high IQ adults
Can IQ compensate for ADHD symptoms?
IQ and ADHD have separate genetics
How ADHD and Test Taking Speed Affect Intelligence Testing
How IQ Compensates for ADHD in Executive Function
ADHD and estimated life expectancy
Irritability in ADHD
ADHD prevalence among adults with substance use disorder
Driving Anger and Driving Behavior in Adults With ADHD
Adult ADHD and Employment Stats
ADHD among adult workers
Maladaptive Daydreaming and Mental Health
Emotion dysregulation in adults with attention deficit hyperactivity disorder: a meta-analysis
ADHD and Comorbidity Statistics
ADHD and Empathy in Adults
Effects of ADHD in Parents
How do people with ADHD handle emotions?
Daydreaming and Attention in ADHD
Self-Esteem, Self-Efficacy, and Resources in Adults With ADHD
ADHD and Adjusting to College Life
ADHD, Executive Function, and Employment
ADHD and Anxiety: Clinical Significance and Treatment Implications
Vitamins, Minerals, and ADHD
Ritalin and Driving Ability
Does Ritalin improve your driving?
ADHD and Driving in Young Adults
Is Ritalin or Adderall better for driving?
Driving with ADHD and Alcohol
Do non-stimulant medications work for adult ADHD?
Ritalin: The effects of gender and alcohol
Ritalin reduces anxiety in cognitive test
Ritalin, reaction time, and response inhibition in healthy adults
Guanfacine vs Adderall for Adult ADHD
Venlafaxine for Adult ADHD
Ritalin may reduce anxiety in anxious adults without ADHD
Group CBT for Adult ADHD
Does CBT work well with medication for Adult ADHD?
CBT vs. Relaxation for Adult ADHD
ADHD and Skills Training Therapy
Mindfulness vs psychoeducation in adult ADHD: a randomized controlled trial
ADHD Psychotherapy and Skills Training
Structured Group Psychotherapy for ADHD
Efficacy of Meta-Cognitive Therapy (MCT) for Adult ADHD
Mindfulness CBT for ADHD
ADHD Medication and Blood Pressure
Working Memory and College Performance
Ritalin, Adderall, and Risks in Pregnancy
Atomoxetine in Adults with ADHD: Two Randomized, Placebo-Controlled Studies
Once-Daily Atomoxetine for Adult Attention-Deficit/Hyperactivity Disorder
Emotional dysregulation in adult ADHD and response to atomoxetine
Can you drink alcohol with Strattera (atomoxetine)?
Strattera and Social Anxiety in Adults
Effects of stimulants and atomoxetine on emotional lability in adults: A systematic review and meta-analysis
Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders
ADHD Meds & Heart Risk in Adults
Does Ritalin increase the risk of mania in those with Bipolar Disorder?
How often do teenagers use stimulants with other substances?
Irritability with Stimulants
Stimulant Medication and Substance Use Outcomes: A Meta-analysis

Evidence Based Answers

Stimulant Medication and Substance Use Outcomes: A Meta-analysis

Kathryn L. Humphreys, MA, EdM, Timothy Eng, BS, and Steve S. Lee, PhD
Summarized by Charles Li, MD
November 15, 2022

🤔
Do stimulant medications for ADHD increase the risk of substance use later in life?
đź’Š
This meta-analysis combined data from 15 studies that looked at substance use in individuals who were prescribed stimulants.
👍
The researchers did not find a statistically significant link between stimulant prescriptions and substance use later in life.

Do stimulant medications lead to substance abuse? Stimulant medications do not significantly increase the risk of substance use later in life.

Background

Stimulants are first-line treatments for ADHD in adults and children.

They are some of the most effective treatments we have for ADHD, and they have been safely prescribed and taken by millions of patients.

However, they are controlled substances with a high risk of addiction. They are closely related in mechanism and chemistry to common illicit drugs.

Researchers in this study wanted to run a meta-analysis to gather data on whether ADHD treatment with stimulants is associated with a higher risk of substance abuse later in life.

Study Quote
Humphreys et al, JAMA Psychiatry

Psychostimulant cation is an efficacious treatment for childhood attention-deficit/hyperactivity disorder, yet controversy remains regarding potential iatrogenic effects of stimulant cation, particularly with respect to increasing susceptibility to later substance use disorders. However,...

Show More

Methods

Researchers analyzed data from 15 studies that looked at lifetime substance use risk in patients who had been prescribed stimulants.

These studies covered 2,565 total patients.

By running a meta-analysis, researchers combined insights from different studies into one result for each substance. This result estimates how likely a person prescribed stimulants is to use a particular substance compared to someone who was not.

For example, the chart below shows the data for marijuana abuse. Some studies found positive correlations and others found negative correlations. When combined, the researchers found that the effect size was non-significant.

What is a meta-analysis?
Stimulants for ADHD do not increase the risk of marijuana abuse later in life
Study Quote
Humphreys et al, JAMA Psychiatry

Data Sources: Studies published between January 1980 and February 2012 were identified using review articles, PubMed, and pertinent listservs. Study Selection: Studies with longitudinal designs in which cation treatment preceded the measurement of substance outcomes. Data Extraction an...

Show More

Results

For each of the substances studied, researchers gathered data from between three and 11 studies to generate their estimates.

Overall, they found that individuals who were prescribed a stimulant were not more likely to use a potentially addictive substance.

All differences were well within the margin of error.

One meta-analysis found that stimulants did not significantly increase or decrease the risk of substance abuse.

Study Quote
Humphreys et al, JAMA Psychiatry

Results: Separate random-effects analyses were conducted for each substance outcome, with the number of studies ranging from 3 to 11 for each outcome. Results suggested comparable outcomes between children with and without cation treatment history for any substance use and abuse or depen...

Show More

Conclusions

This is an encouraging result for those with ADHD and those considering stimulants.

These results tell us that at the moment, there is no conclusive evidence that stimulants increase the risk of substance use later in life.

It’s important to keep in mind however that just because we haven’t found significant risk doesn’t mean that there isn’t a risk of substance use later in life.

Larger studies may be able to uncover significant risks that small studies aren’t powerful enough to unveil.

Study Quote
Humphreys et al, JAMA Psychiatry

Conclusions: These results provide an important update and suggest that treatment of attention-deficit/hyperactivity disorder with stimulant cation neither protects nor increases the risk of later substance use disorders.